CSS
CASI

Cubist Systematic Strategies’s CASI Pharmaceuticals CASI Stock Holding History

Cubist Systematic Strategies’s Portfolio CASI Stock Details CASI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-21,843
Closed -$260K – 3470
2021
Q3 		$260K Buy
21,843
+19,724
+931% +$267K ﹤0.01% 2439
2021
Q2 		$33K Buy
2,119
+9
+0.4% +$151 ﹤0.01% 2822
2021
Q1 		$51K Buy
2,110
+717
+51% +$20.1K ﹤0.01% 2731
2020
Q4 		$41K Buy
+1,393
New +$30.3K ﹤0.01% 2477

Other funds holding CASI

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WSCM
Wellington Shields Capital Management New York $788M AUM 66.95% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
WSC
Wellington Shields & Co New York $446M AUM 38.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Cubist Systematic Strategies's CASI Position: Q4 2021 in Review

Cubist Systematic Strategies sold out of CASI Pharmaceuticals (CASI) in Q4 2021, closing a stake of 21,843 shares — an estimated $260K sold.

Cubist Systematic Strategies first reported a position in CASI in Q4 2020 and held it in 4 quarters. The position peaked at $260K in Q3 2021. 51 funds tracked by Wall St. Rank hold CASI as of Q4 2021.

  • Cubist Systematic Strategies reported no remaining CASI Pharmaceuticals position as of Q4 2021 after selling out during the quarter.
  • Cubist Systematic Strategies sold 21,843 CASI Pharmaceuticals shares in Q4 2021, an estimated $260K.
  • Cubist Systematic Strategies first reported a position in CASI Pharmaceuticals in Q4 2020 and held it in 4 quarters.
  • Cubist Systematic Strategies's CASI Pharmaceuticals position peaked at $260K in Q3 2021.
  • 51 funds tracked by Wall St. Rank held CASI Pharmaceuticals as of Q4 2021.

Based on Cubist Systematic Strategies's 13F filing for Q4 2021, filed 14 Feb 2022.